Merial Can't Force Recall Of Generic Flea Repellent
Law360, New York (August 24, 2011, 3:40 PM EDT) -- A Georgia federal judge ruled Tuesday he could not force two manufacturers to recall from retailers a generic version of Merial Ltd.'s Frontline Plus that the company claims infringes its patents covering the blockbuster flea and tick repellent for pets.
Tuesday’s order is the latest development in a long-running patent infringement suit in which Merial maintains Velcera Inc. and Cipla Ltd. worked together in order to sell their generic, PetArmor Plus, in violation of a 2008 judgment enjoining Cipla and any affiliates from infringing Merial’s U.S. Patent Numbers 6,096,329 and 5,232,940.
“If Velcera’s retail partners are permitted to sell their remaining inventory...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Kirkland & Ellis LLP has redefined what it means to be the biggest of BigLaw — weighing in at 2,116 attorneys by year end 2018 and becoming the first firm since Law360 began tracking law firm head counts to top 2,000 U.S.-based attorneys.